During the past decade, Woodwinds Health Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 22 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woodwinds Health Campus" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woodwinds Health Campus" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Woodwinds Health Campus" are "Breast Cancer" (6 trials), "Lung Cancer" (4 trials), "Recurrent Breast Carcinoma" (3 trials), "Adenocarcinoma of the Prostate" (2 trials) and "Adult Glioblastoma" (2 trials). Many other conditions were trialed in "Woodwinds Health Campus" in a lesser frequency.

Most popular intervention types in "Woodwinds Health Campus" are "Drug" (39 trials), "Other" (18 trials), "Biological" (12 trials), "Radiation" (8 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Bevacizumab" (8 trials), "Quality-of-Life Assessment" (5 trials), "Radiation Therapy" (4 trials) and "bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Woodwinds Health Campus" are 31 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Woodwinds Health Campus". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Woodwinds Health Campus, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Woodwinds Health Campus, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Woodwinds Health Campus has several departments that took part in Clinical trials: "HealthEast Cancer Care at Woodwinds Health Campus" - 28 trials, "Fairview Southdale Medical Oncology Clinic" - 12 trials, "Explorer Clinic, University of Minnesota Children's Hospital" - 2 trials, "Ambulatory Research Center/Fairview University Psychiatry Dept" - 2 trials, "Minnesota Heart Clinic" - 2 trials